Semi-Annual Statement Of Cash Flows

JCR Pharmaceuticals Co.,Ltd. - Filing #7326592

Concept 2023-04-01 to
2024-03-31
As at
2024-03-31
As at
2023-03-31
2022-04-01 to
2023-03-31
As at
2022-03-31
Semi-annual statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
7,280,000,000 JPY
2,762,000,000 JPY
Interest and dividends received
138,000,000 JPY
62,000,000 JPY
Interest paid
-87,000,000 JPY
-46,000,000 JPY
Net cash provided by (used in) operating activities
9,312,000,000 JPY
-5,500,000,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-1,526,000,000 JPY
-7,654,000,000 JPY
Other, net
5,000,000 JPY
15,000,000 JPY
Net cash provided by (used in) investing activities
-2,690,000,000 JPY
-15,002,000,000 JPY
Cash flows from financing activities
Proceeds from long-term borrowings
9,600,000,000 JPY
4,750,000,000 JPY
Repayments of long-term borrowings
-1,700,000,000 JPY
-3,050,000,000 JPY
Redemption of bonds
-500,000,000 JPY
JPY
Dividends paid
-2,500,000,000 JPY
-2,739,000,000 JPY
Net cash provided by (used in) financing activities
-2,031,000,000 JPY
1,948,000,000 JPY
Other, net
-46,000,000 JPY
-22,000,000 JPY
Effect of exchange rate change on cash and cash equivalents
886,000,000 JPY
1,099,000,000 JPY
Net increase (decrease) in cash and cash equivalents
5,477,000,000 JPY
-17,454,000,000 JPY
Cash and cash equivalents
18,756,000,000 JPY
13,278,000,000 JPY
30,733,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.